These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30386737)

  • 1. Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy.
    Cormio L; Cindolo L; Troiano F; Marchioni M; Di Fino G; Mancini V; Falagario U; Selvaggio O; Sanguedolce F; Fortunato F; Schips L; Carrieri G
    Front Oncol; 2018; 8():438. PubMed ID: 30386737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
    Huang C; Song G; Wang H; Ji G; Li J; Chen Y; Fan Y; Fang D; Xiong G; Xin Z; Zhou L
    Biomed Res Int; 2018; 2018():6368309. PubMed ID: 30276213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of a novel nomogram to predict prostate cancer in biopsy-naïve patients with PSA <10 ng/ml and PI-RADS v2.1 = 3 lesions.
    Hu C; Sun J; Xu Z; Zhang Z; Zhou Q; Xu J; Chen H; Wang C; Ouyang J
    Cancer Med; 2023 Feb; 12(3):2560-2571. PubMed ID: 35920264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer.
    Wagaskar VG; Levy M; Ratnani P; Moody K; Garcia M; Pedraza AM; Parekh S; Pandav K; Shukla B; Prasad S; Sobotka S; Haines K; Punnen S; Wiklund P; Tewari A
    Eur Urol Open Sci; 2021 Jun; 28():9-16. PubMed ID: 34337520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
    Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
    Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers.
    Cindolo L; Bertolo R; Minervini A; Sessa F; Muto G; Bove P; Vittori M; Bozzini G; Castellan P; Mugavero F; Falsaperla M; Schips L; Celia A; Bada M; Porreca A; Pastore A; Al Salhi Y; Giampaoli M; Novella G; Rizzetto R; Trabacchin N; Mantica G; Pini G; Lombardo R; Tubaro A; Antonelli A; De Nunzio C
    World J Urol; 2020 Oct; 38(10):2555-2561. PubMed ID: 31907633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
    Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
    Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies.
    Falagario UG; Busetto GM; Recchia M; Tocci E; Selvaggio O; Ninivaggi A; Milillo P; Macarini L; Sanguedolce F; Mancini V; Annese P; Bettocchi C; Carrieri G; Cormio L
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study.
    Bruno SM; Falagario UG; d'Altilia N; Recchia M; Mancini V; Selvaggio O; Sanguedolce F; Del Giudice F; Maggi M; Ferro M; Porreca A; Sciarra A; De Berardinis E; Bettocchi C; Busetto GM; Cormio L; Carrieri G
    Front Oncol; 2021; 11():693684. PubMed ID: 34094990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy.
    Falagario UG; Busetto GM; Netti GS; Sanguedolce F; Selvaggio O; Infante B; Ranieri E; Stallone G; Carrieri G; Cormio L
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator.
    Parekh S; Ratnani P; Falagario U; Lundon D; Kewlani D; Nasri J; Dovey Z; Stroumbakis D; Ranti D; Grauer R; Sobotka S; Pedraza A; Wagaskar V; Mistry L; Jambor I; Lantz A; Ettala O; Stabile A; Taimen P; Aronen HJ; Knaapila J; Perez IM; Gandaglia G; Martini A; Picker W; Haug E; Cormio L; Nordström T; Briganti A; Boström PJ; Carrieri G; Haines K; Gorin MA; Wiklund P; Menon M; Tewari A
    Eur Urol Open Sci; 2022 Jul; 41():45-54. PubMed ID: 35813258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer.
    Cormio L; Lucarelli G; Netti GS; Stallone G; Selvaggio O; Troiano F; Di Fino G; Sanguedolce F; Bufo P; Grandaliano G; Carrieri G
    Anticancer Res; 2015 Apr; 35(4):2175-82. PubMed ID: 25862875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies.
    Borque-Fernando Á; Esteban LM; Celma A; Roche S; Planas J; Regis L; de Torres I; Semidey ME; Trilla E; Morote J
    World J Urol; 2020 Jun; 38(6):1481-1491. PubMed ID: 31506748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study.
    Huang C; Cai ZQ; Qiu F; Pu JX; Xi QL; Wei XD; Wang XM; Zhao XJ; Guo LC; Hou JQ; Huang YH
    Asian J Androl; 2023; 25(1):126-131. PubMed ID: 35488668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
    Sun J; Zhang Z; OuYang J
    Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performing Precise Biopsy in Naive Patients With Equivocal PI-RADS, Version 2, Score 3, Lesions: An MRI-based Nomogram to Avoid Unnecessary Surgical Intervention.
    Zhang Y; Zeng N; Zhang FB; Rui Huang YX; Tian Y
    Clin Genitourin Cancer; 2020 Oct; 18(5):367-377. PubMed ID: 32771334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy.
    Yu S; Hong G; Tao J; Shen Y; Liu J; Dong B; Fan Y; Li Z; Zhu A; Zhang X
    Front Oncol; 2020; 10():575261. PubMed ID: 33262944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
    Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
    Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
    Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
    J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.